In this peer-to-peer discussion, Prof Dhiraj Gupta, Liverpool Heart and Chest Hospital, and Dr Hugh Calkins, Johns Hopkins Medicine, summarise the AF-related updates to the European guidelines, discuss the studies that have underpinned the changes, and consider the NOAC choices for pericatheter ablation, the utilisation of NOACs with and without interruption, and the length of anticoagulation post-ablation.
Learning Objectives
- Recall recent changes to the ESC atrial fibrillation guidelines with respect to individuals undergoing catheter ablation
- Summarise the results from studies that have influenced recent guideline changes
- Outline practical approaches to initiate NOAC therapy in individuals undergoing ablation